Home

PAR-20-292 - NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 4

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer NOT-CA-22-085 NCI May 5, 2022 Jul 5, 2027 K22, R01, K08, K01, R21, R03, K99/R00
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity NOT-CA-22-001 NCI , NHLBI Nov 4, 2021 Nov 6, 2024 R01, R03, R21, P01
Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention NOT-CA-21-121 NCI Oct 4, 2021 Sep 8, 2024 K22, K08, R15, R01, R21, K99/R00,
Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules NOT-CA-21-101 NCI Aug 16, 2021 Jan 8, 2024 R01, R15, R21

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health